Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses

References

• Ferlay J, Soerjomataram I, Ervik M, . (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon (France): International Agency for Research on Cancer; Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx [last accessed 2015 Jun 30].
   Google Scholar
• Gaffney DK, Suneja G, Ryu SY, . (2015). The cervix cancer research network: a global outreach effort on behalf of the Gynecologic Cancer InterGroup. Int J Radiat Oncol Biol Phys 92:506–08.
   PubMed Web of Science ®Google Scholar
• Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. (2008). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26:5802–12.
   PubMed Web of Science ®Google Scholar
• Hanna TP, Shafiq J, Delaney GP, . (2015). The population benefit of radiotherapy for cervical cancer: local control and survival estimates for optimally utilized radiotherapy and chemoradiation. Radiother Oncol 114:389–94.
   PubMed Web of Science ®Google Scholar
• Datta NR, Ordonez SG, Gaipl US, . (2015). Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev 41:742–53.
   PubMed Web of Science ®Google Scholar
• Issels RD. (2008). Hyperthermia adds to chemotherapy. Eur J Cancer 44:2546–54.
   PubMed Web of Science ®Google Scholar
• Lim K, Chan P, Dinniwell R, . (2008). Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys 70:126–33.
   PubMed Web of Science ®Google Scholar
• Lutgens L, van der Zee J, Pijls-Johannesma M, . (2010). Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev CD006377.
   Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, . (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700.
   PubMed Web of Science ®Google Scholar
• Hutton B, Salanti G, Caldwell DM, . (2015). The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162:777–84.
   PubMed Web of Science ®Google Scholar
• Chen HW, Jei J, Wei L. (1997). A randomized trial of hyperthermoradiochemotherapy for uterine cervix. Chin J Oncol 24:249–51.
   Google Scholar
• Yan X, Liu W, Yan Z, . (2014). Efficacy and safety radio-chemotherapy combined with thermotherapy for cervical cancer: a meta-analysis. Chin J Evid-based Med 14:752–58.
   Google Scholar
• Franckena M, Stalpers LJ, Koper PC, . (2008). Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70:1176–82.
   PubMed Web of Science ®Google Scholar
• Harima Y, Nagata K, Harima K, . (2009). A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 25:338–43.
   PubMed Web of Science ®Google Scholar
• Datta NR, Bose AK, Kapoor HK. (1987). Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): a controlled clinical study. Ind Med Gazette 121:68–71.
   Google Scholar
• Vasanthan A, Mitsumori M, Park JH, . (2005). Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 61:145–53.
   PubMed Web of Science ®Google Scholar
• Sharma S, Singhal S, Sandhu AP, . (1991). Local thermo-radiotherapy in carcinoma cervix: improved local control versus increased incidence of distant metastasis. Asia Oceania J Obstet Gynaecol 17:5–12.
   PubMedGoogle Scholar
• van der Zee J, González D, van Rhoon G, . (2000). Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet 355:1119–25.
   PubMed Web of Science ®Google Scholar
• Harima Y, Nagata K, Harima K, . (2001). A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17:97–105.
   PubMed Web of Science ®Google Scholar
• Sharma S, Sandhu AP, Patel FD, . (1990). Side-effects of local hyperthermia: results of a prospectively randomized clinical study. Int J Hyperthermia 6:279–85.
   PubMed Web of Science ®Google Scholar
• Lutgens LC, Koper PC, Jobsen JJ, . (2016). Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: results of the randomized RADCHOC trial. Radiother Oncol DOI:10.1016/j.radonc.2016.02.010.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Altman DG, Gotzsche PC, . (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928.
   PubMed Web of Science ®Google Scholar
• Comprehensive Meta-analysis Software, version 3.0. Available from: http://www.meta-analysis.com/index.php [last accessed 25 May 2015].
   Google Scholar
• Schünemann HJ, Oxman AD, Vist GE, . (2008). Interpreting results and drawing conclusions. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Chichester: John Wiley, 359–89.
   Google Scholar
• Begg CB, Mazumdar M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–101.
   PubMed Web of Science ®Google Scholar
• Brown S, Hutton B, Clifford T, . (2014). A Microsoft-Excel-based tool for running and critically appraising network meta-analyses – an overview and application of NetMetaXL. Syst Rev 3:110.
   PubMedGoogle Scholar
• NetMetaXL. Available from: http://www.netmetaxl.com/.
   Google Scholar
• Xiong T, Turner RM, Wei Y, . (2014). Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis. BMJ Open 4:e004285.
   Web of Science ®Google Scholar
• Caldwell DM, Ades AE, Higgins JP. (2005). Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 331:897–900.
   PubMed Web of Science ®Google Scholar
• Hutton B, Salanti G, Chaimani A, . (2014). The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement. PLoS One 9:e92508.
   PubMed Web of Science ®Google Scholar
• Datta NR, Pasricha R, Singh U, . (2004). Predictors of survival end points in patients with cancer of the cervix on long-term follow-up: inferences and implications from an audit of patients treated with a specific radiotherapy protocol. Clin Oncol (R Coll Radiol) 16:536–42.
   PubMed Web of Science ®Google Scholar
• Chen SW, Liang JA, Yang SN, . (2003). The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol 67:69–76.
   PubMed Web of Science ®Google Scholar
• Hong JH, Chen MS, Lin FJ, . (1992). Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 22:913–17.
   PubMed Web of Science ®Google Scholar
• Saibishkumar EP, Patel FD, Sharma SC, . (2006). Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: a retrospective analysis of 556 patients from India. Radiother Oncol 79:142–46.
   PubMed Web of Science ®Google Scholar
• Jacobs AJ, Faris C, Perez CA, . (1986). Short-term persistence of carcinoma of the uterine cervix after radiation. An indicator of long-term prognosis. Cancer 57:944–50.
   PubMed Web of Science ®Google Scholar
• Jones EL, Prosnitz LR, Dewhirst MW, . (2005). In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys (2005). 61:145–153). Int J Radiat Oncol Biol Phys 63:644.
   PubMed Web of Science ®Google Scholar
• Franckena M, Lutgens LC, Koper PC, . (2009). Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients. Int J Radiat Oncol Biol Phys 73:242–50.
   PubMed Web of Science ®Google Scholar
• Zolciak-Siwinska A, Piotrkowicz N, Jonska-Gmyrek J, . (2013). HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy – a phase III study. Radiother Oncol 109:194–99.
   PubMed Web of Science ®Google Scholar
• Westermann A, Mella O, Van Der Zee J, . (2012). Long-term survival data of triple modality treatment of stage IIB–III–IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia – an update. Int J Hyperthermia 28:549–53.
   PubMed Web of Science ®Google Scholar
• Westermann AM, Jones EL, Schem BC, . (2005). First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 104:763–70.
   PubMed Web of Science ®Google Scholar
• Datta NR, Kumar P, Singh S, . (2006). Does pretreatment human papillomavirus (HPV) titers predict radiation response and survival outcomes in cancer cervix? – a pilot study. Gynecol Oncol 103:100–5.
   PubMed Web of Science ®Google Scholar
• Datta NR, Singh S, Kumar P, . (2015). Human papillomavirus confers radiosensitivity in cancer cervix: a hypothesis toward a possible restoration of apoptotic pathways based on clinical outcomes. Future Oncol 11:1363–71.
   PubMed Web of Science ®Google Scholar
• Oei AL, van Leeuwen CM, Ten Cate R, . (2015). Hyperthermia selectively targets human papillomavirus in cervical tumors via p53-dependent apoptosis. Cancer Res 75:5120–29.
   PubMed Web of Science ®Google Scholar
• Westermann AM. (2013). Cisplatin combined with radiation therapy and hyperthermia in treating patients with stage II, stage III, or stage IV cervical cancer: ClinicalTrials.gov; ClinicalTrials.gov identifier: NCT00008112. Available from: https://clinicaltrials.gov/ct2/show/NCT00008112?term=NCT00008112&rank = 1 [last accessed 30 Jun 2015].
   Google Scholar
• Dewhirst MW. (2013). Cisplatin and radiation therapy with or without hyperthermia therapy in treating patients with cervical cancer: ClinicalTrials.gov; ClinicalTrials.gov identifier: NCT00085631. Available from: https://clinicaltrials.gov/ct2/show/NCT00085631?term=NCT00085631&rank =1 [last accessed 30 Jun 2015].
   Google Scholar